VEGFD and hematocrit: In advanced HF, high plasma VEGF-D and sFlt-1 levels decreased most markedly at the 4 weeks follow-up, as well as vs 6 months and 1 year after HT (FDR = 1%, p < 0.01, all groups vs before-HT; Figures 2 and 3).